A synthetic opsin restores vision in patients with severe retinal degeneration
Top Cited Papers
Open Access
- 22 March 2025
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 33 (5) , 2279-2290
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Safety of intravitreally delivered AAV2 vector‐mediated multi‐characteristic opsin genetic construct in wild type beagle dogsThe Journal of Gene Medicine, 2024
- Elucidating the structural and functional uniqueness of multi-characteristic opsin, a highly bioengineered, ambient light-sensitive molecule, with broadband spectral responsiveness and fast kinetics to modulate neural activitiesBiophysical Journal, 2024
- Photopharmacology for vision restorationCurrent Opinion in Pharmacology, 2022
- Intrinsisch photosensitive retinale GanglienzellenDer Ophthalmologe, 2021
- Supramolecular organization of rhodopsin in rod photoreceptor cell membranesPflügers Archiv - European Journal of Physiology, 2021
- A pathoconnectome of early neurodegeneration: Network changes in retinal degenerationExperimental Eye Research, 2020
- Efficacy and Safety of Glycosidic Enzymes for Improved Gene Delivery to the Retina following Intravitreal Injection in MiceMolecular Therapy - Methods & Clinical Development, 2018
- Mutations of 60 known causative genes in 157 families with retinitis pigmentosa based on exome sequencingHuman Genetics, 2014
- Perspective on Genes and Mutations Causing Retinitis PigmentosaArchives of Ophthalmology (1950), 2007
- Identifying Retinal Disease Genes: How Far Have We Come, How Far Do We Have to Go?2003